[1]Ye Q,Zheng MH,Cai Q,et al.Aberrant expression and demethylation of γ-synuclein in colorectal cancer,correlated with progression of the disease[J].Cancer Sci,2008,99(10):1924-1932.
[2]Nishioka K,Wider C,Vilario-Güell C,et al.Association of alpha-,beta-,and gamma-Synuclein with diffuse lewy body disease[J].Arch Neurol,2010,67(8):970-975.
[3]Surguchov A.Synucleins:are they two-edged swords[J]?J Neurosci Res,2013,91(2):161-166.
[4]Gupta A,Inaba S,Wong OK,et al.Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR[J].Oncogene,2003,22(48):7593-7599.
[5]Miao S,Wu K,Zhang B,et al.Synuclein γ compromises spindle assembly checkpoint and renders resistance to antimicrotubule drugs[J].Mol Cancer Ther,2014,13(3):699-713.
[6]Jiang Y,Liu YE,Goldberg ID,et al.Gamma synuclein,a novel heat-shock protein-associated chaperone,stimulates ligand-dependent estrogen receptor alpha signaling and mammary tumorigenesis[J].Cancer Res,2004,64(13):4539-4546.
[7]Liu YE,Pu W,Jiang Y,et al.Chaperoning of estrogen receptor and induction of mammary gland proliferation by neuronal protein synuclein gamma[J].Oncogene,2007,26(14):2115-2125.
[8]Shi YE,Chen Y,Dackour R,et al.Synuclein gamma stimulates membrane-initiated estrogen signaling by chaperoning estrogen receptor (ER)-alpha36,a variant of ER-alpha[J].Am J Pathol,2010,177(2):964-973.
[9]Liang W,Miao S,Zhang B,et al.Synuclein γ protects Akt and mTOR and renders tumor resistance to Hsp90 disruption[J].Oncogene,2015,34(18):2398-2405.
[10]Shao Y,Wang B,Shi D,et al.Synuclein gamma protects HER2 and renders resistance to Hsp90 disruption[J].Mol Oncol,2014,8(8):1521-1531.
[11]Pan ZZ,Bruening W,Giasson BI,et al.γ-Synuclein promotes cancer cell survival and inhibits stress-and chemotherapy drug-induced apoptosis by modulating MAPK pathways[J].J Biol Chem,2002,277(38):35050-35060.
[12]He J,Xie N,Yang J,et al.siRNA-mediated suppression of synuclein γ inhibits MDA-MB-231 Cell migration and proliferation by downregulating the phosphorylation of AKT and ERK[J].J Breast Cancer,2014,17(3):200-206.
[13]Zhuang Q,Liu C,Qu L,et al.Synuclein-γ promotes migration of MCF7 breast cancer cells by activating extracellular-signal regulated kinase pathway and breaking cell-cell junctions[J].Mol Med Rep,2015,12(3):3795-3800.
[14]Ye Q,Wang TF,Peng YF,et al.Expression of α-,β-and γ-synuclein in colorectal cancer,and potential clinical significance in progression of the disease[J].Oncol Rep,2010,23(2):429-436.
[15]Liang B,Wang XJ,Shen PH,et al.Synuclein-γ suppression mediated by RNA interference inhibits the clonogenicity and invasiveness of MCF-7 cells[J].Oncol Lett,2013,5(4):1347-1352.
[16]He K,Wang P.Unregulated long non-coding RNA-AK058003 promotes the proliferation,invasion and metastasis of breast cancer by regulating the expression levels of the γ-synuclein gene[J].Exp Ther Med,2015,9(5):1727-1732.
[17]Singh VK,Zhou Y,Marsh JA,et al.Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs[J].Cancer Res,2007,67(2):626-633.
[18]Manivel P,Muthukumaran J,Kannan M,et al.Insight into residues involved in the structure and function of the breast cancer associated protein human gamma synuclein[J].J Mol Model,2011,17(2):251-263.